Ethyl 3-(4-Isopropylphenyl)Acrylate

Ethyl 3-(4-Isopropylphenyl)Acrylate

SCHEMBL526299

CCOC(=O)/C=C/c1ccc(C(C)C)cc1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.69
CA1 P00915 1/20 0.69
CA2 P00918 1/20 0.69
CA7 P43166 1/20 0.69
CA9 Q16790 1/20 0.69
CA14 Q9ULX7 1/20 0.69
KDM4E B2RXH2 2/20 0.60
MAPK1 P28482 1/20 0.60
CYP3A4 P08684 1/20 0.60
TTR P02766 1/20 0.59
DPP4 P27487 1/20 0.59
SMN1; SMN2 Q16637 3/20 0.56
ALDH1A1 P00352 3/20 0.56
LMNA P02545 3/20 0.56
RAB9A P51151 3/20 0.55
NPC1 O15118 2/20 0.55
POLB P06746 1/20 0.55
MAOB P27338 1/20 0.54
BCHE P06276 1/20 0.53
ACHE P22303 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL156247 1.00 CA12 (0.69) CA12CA1CA2CA7CA9
Ethyl Cinnamate SCHEMBL28554385 0.90 KDM4E (0.66) CA12CA1CA2CA7CA9
Ethyl Cinnamate SCHEMBL28554384 0.90 KDM4E (0.66) CA12CA1CA2CA7CA9
Ethyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL28182168 0.89 PTGS2 (0.61) CA12CA1CA2CA7CA9
Ethyl 3-(4-Isopropylphenyl)Acrylate SCHEMBL28182167 0.89 PTGS2 (0.61) CA12CA1CA2CA7CA9
SCHEMBL10939791 0.88 CA12 (0.86) CA12CA1CA2CA7CA9
SCHEMBL13957401 0.88 CA12 (0.86) CA12CA1CA2CA7CA9
SCHEMBL5059085 0.88 CA12 (0.86) CA12CA1CA2CA7CA9
SCHEMBL10904660 0.88 CA12 (0.65) CA12CA1CA2CA7CA9
SCHEMBL10904659 0.88 CA12 (0.65) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 787 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190299032-A1 Oil-In-Water Type Emulsion Cosmetic Composition SHISEIDO COMPANY, LTD. (JP) 2019-10-03 US claimed
US-20180056096-A1 Oil-In-Water Type Emulsion Cosmetic Composition SHISEIDO CO., LTD. (JP) 2018-03-01 US claimed
CN-105407718-A Coated particles and compositions comprising the same VYOME BIOSCIENCES 2016-03-16 CN claimed
CN-101282708-B External preparation for skin containing a phosphorlated saccharide EZAKI GLICO CO 2013-03-20 CN claimed
US-8168227-B2 Modified powder and cosmetic composition using the same SHISEIDO CO., LTD. (JP) 2012-05-01 US claimed
CN-1679475-B Hair cosmetic composition KAO CORP 2010-06-16 CN claimed
US-20070253989-A1 Modified Powder and Cosmetic Composition Using the Same SHISEIDO CO., LTD. (JP) 2007-11-01 US claimed
US-20020131939-A1 Hair protection compositions ROCHE VITAMINS INC. 2002-09-19 US claimed
US-12564549-B2 Cleanser composition SHISEIDO COMPANY, LTD. (JP) 2026-03-03 US disclosed
US-20250319013-A1 THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-10-16 US disclosed
US-12419822-B2 Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same TOTALENERGIES ONETECH (FR) 2025-09-23 US disclosed
US-12403077-B2 Use of a new composition for preventing or slowing the appearance of signs of inflammation SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-09-02 US disclosed
US-12251453-B2 Self-invertible inverse latex comprising polyglycyerol esters, use thereof as a thickening agent, and cosmetic compositions comprising same SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-03-18 US disclosed
US-20250032395-A1 COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS SOCIETE D’EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2025-01-30 US disclosed
EP-0688559-A1 Skin anti-ageing composition SHISEIDO COMPANY LIMITED (JP) 1995-12-27 EP disclosed
US-5427771-A Stable dispersion in cosmetically acceptable vehicle with adjuvants L'OREAL (FR) 1995-06-27 US disclosed
WO-1995009895-A1 ULTRAVIOLET SHIELDING COMPOSITE FINE PARTICLES, METHOD FOR PRODUCING THE SAME, AND COSMETICS KAO CORPORATION (JP) 1995-04-13 WO disclosed
US-5000937-A Transparent cosmetic composition that reflects infrared radiation and its use for protecting the human epidermis against infrared radiation L'OREAL (FR) 1991-03-19 US disclosed
EP-0211183-A2 Use of ubidecarenone(ubiquinone-10) as an antichromatotic agent Eisai Co., Ltd. (JP) 1987-02-25 EP disclosed
US-4284621-A SUNSCREEN FOR SKIN BAYER AKTIENGESELLSCHAFT (DE) 1981-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12251453-B2 Self-invertible inverse latex comprising polyglycyerol esters, use thereof as a thickening agent, and cosmetic compositions comprising same UGCG, DAGLA, DAGLB CA12 1104/4885CA1 3728/4885CA2 3066/4885
US-20190299032-A1 Oil-In-Water Type Emulsion Cosmetic Composition CD44, DSG1, CUTA CA12 862/4885CA1 1970/4885CA2 2323/4885
US-12564549-B2 Cleanser composition LIPA, SGMS1, SGMS2 CA12 1366/4885CA1 2371/4885CA2 3649/4885
US-12419822-B2 Compositions based on alkanes and ester(s) with temperature storage stability, use thereof as softening agents and emulsions comprising same ACOX3, ELOVL3, ACOX1 CA12 1208/4885CA1 2349/4885CA2 832/4885
US-12403077-B2 Use of a new composition for preventing or slowing the appearance of signs of inflammation C1QBP, MDH2, C9 CA12 1419/4885CA1 1035/4885CA2 191/4885
US-20250319013-A1 THICKENING COMPOSITION FOR THICKENING POLAR OR NON-POLAR OILS PHOSPHO1, ELOVL5, PARG CA12 3398/4885CA1 4422/4885CA2 4216/4885
US-20250032395-A1 COPOLYMER THICKENING COMPOSITION COMPRISING AT LEAST ONE OIL AND AT LEAST ONE POLY(ITACONATE) FOR THICKENING POLAR OR APOLAR OILS SOAT1, NOTUM, CPT1A CA12 1973/4885CA1 2983/4885CA2 3695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.